Who
John C. Thomas
Director
Company insider
Files Form 4 as: Director, Dogwood Therapeutics; Director and Other, ImmunityBio; Director, Novelion Therapeutics; Director, Medovex; CFO and Secretary, DARA BioSciences.
In numbers
- Trades disclosed
- 70
- Buys
- 3
- Sells
- 15
- Bought
- $14K
- Sold
- $1.9M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 9 Sep 2008
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,800 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,800 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,362 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,167 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,250 at $0.00 | filing |
| 23 Jun 2022filed 30 Jun 2022 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,250 at $0.00 | filing |
| 4 Jan 2022filed 4 Jan 2022 | DWTX Dogwood TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,6501,000 at $5.65 | filing |
| 22 Jun 2021filed 23 Jun 2021 | DWTX Dogwood Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,875 at $0.00 | filing |
| 23 Feb 2021filed 28 Jan 2022 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 10 Dec 2020filed 11 Dec 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $461K42,592 at $10.83 | filing |
| 19 Aug 2020filed 21 Aug 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $184K20,000 at $9.19 | filing |
| 13 Aug 2020filed 13 Aug 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $190K20,000 at $9.49 | filing |
| 13 Aug 2020filed 13 Aug 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $187K20,000 at $9.34 | filing |
| 11 Aug 2020filed 13 Aug 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $205K19,790 at $10.35 | filing |
| 11 Aug 2020filed 13 Aug 2020 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $2,216210 at $10.55 | filing |
| 10 Jun 2020filed 11 Jun 2020 | IBRX ImmunityBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 16 Dec 2019filed 16 Dec 2019 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $31K10,000 at $3.14 | filing |
| 13 Dec 2019filed 16 Dec 2019 | IBRX ImmunityBioBiotechnology | SEC FORM 4 Sold | $25K10,000 at $2.48 | filing |
News
ImmunityBio (NASDAQ:IBRX) Shares Down 6.4% – Here's WhyIBRX · dailypolitical.com · 19 Oct 2026Dogwood Therapeutics, Inc (NASDAQ:DWTX) Sees Significant Drop in Short InterestDWTX · themarketsdaily.com · 14 Oct 2026ImmunityBio (NASDAQ:IBRX) Director Cheryl Cohen Sells 81,056 Shares of StockIBRX · tickerreport.com · 7 Oct 2026
0 headlines in the last 90 days name John C. Thomas; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.